euro adhoc: Sartorius AG / Dr.Ralf Hermann will leave Vivascience AG (E)

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.

Effective June 30 2003, Dr. Ralf Hermann will resign from his position as Chairman of the Executive Board of Vivascience AG, biotech suppliers and proteomics specialists. Dr. Hermann will leave the Executive Board of Vivascience as of 31 December 2003. Vivascience AG, headquartered in Hanover, Germany, is a wholly-owned subsidiary of Sartorius AG.

Further inquiry note:
Thomas Hartwig
CFO
49 551/3083871
Tel: +49 (0)551 308 0
FAX: +49 (0)551 308 289
Email: info.investors@sartorius.com

Emittent: Sartorius AG Weender Landstr. 94-108 DE-37075 Göttingen Tel: +49 (0)551 308 0 FAX: +49 (0)551 308 289 Email: info.investors@sartorius.com WWW: http://www.sartorius.com ISIN: DE0007165607 WKN: 716560

end of announcement euro adhoc

Indizes: CDAX, Prime All Share, Prime Standard, Technologie All Share
Börsen: official dealing Niedersächsische Börse zu Hannover, Frankfurter Wertpapierbörse; free trade Berliner Wertpapierbörse, Bayerische Börse, Hamburger Wertpapierbörse, Bremer Wertpapierbörse (BWB), Börse Düsseldorf, Baden-Württembergische Wertpapierbörse Branche: Biotechnology
Sprache: Englisch

OTS-ORIGINALTEXT UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS | OTB0009